United States: Yearly Stock Market Performance Insight - 2023

Yearly Gainers
2,618
Yearly Losers
2,617
Average Return
47.78%
Total Stocks
5,449
View Detailed Market Cap Breakdown
Market Cap Yearly Gainers Yearly Losers Average Return Total Stocks
Mega Cap 38 9 720.33% 47
Large Cap 503 193 28.25% 700
Mid Cap 644 281 57.67% 947
Small Cap 268 213 101.20% 490

Yearly Streak Leaders for 2023

Stock Streak Streak Return
8 years โ†‘ 178.27%

Berkshire Hathaway continues its impressive multi-year expansion with a 8-year growth streak (195,000.00 โ†’ 542,625.00), delivering 178.3% cumulative returns. With 83.3B annual revenue generating only 4.7B profit (5.6% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

8 years โ†‘ 174.02%

Berkshire Hathaway solidifies its market leadership with a 8-year growth streak (130.16 โ†’ 356.66), delivering 174.0% cumulative returns. With 83.3B annual revenue generating only 4.7B profit (5.6% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

4 years โ†“ -43.27%

AT&T struggles through multi-year headwinds with a 4-year decline (29.58 โ†’ 16.78), down 43.3% cumulatively. Yet fundamentals remain solid: 30.6B annual revenue generating 4.7B profit (15.3% margin) as of Qtr ending Mar 2025 suggests this could be a value opportunity. Contrarian investors take note.

2 years โ†“ -9.37%

Procter & Gamble encounters consecutive annual declines with a 2-year decline (161.69 โ†’ 146.54), down 9.4% cumulatively. Yet fundamentals remain solid: 19.8B annual revenue generating 3.8B profit (19.2% margin) as of Qtr ending Mar 2025 suggests this could be a value opportunity. Contrarian investors take note.

15 years โ†‘ 2,388.20%

Gartner continues its impressive multi-year expansion with a 15-year growth streak (18.13 โ†’ 451.11), delivering 2,388.2% cumulative returns. With 1.7B annual revenue generating only 398.6M profit (23.2% margin) in Qtr ending Dec 2024, the market prices in significant margin expansion ahead.

15 years โ†‘ 2,493.12%

Cintas demonstrates exceptional long-term growth with a 15-year growth streak (5.81 โ†’ 150.66), delivering 2,493.1% cumulative returns. Annual financials validate this performance: 2.6B revenue generating 463.5M net profit (17.8% margin) demonstrates exceptional profit margins as of Qtr ending Feb 2025.

6 years โ†“ -74.43%

Viatris faces prolonged challenges with a 6-year decline (42.35 โ†’ 10.83), down 74.4% cumulatively. Financial struggles compound yearly losses: despite 3.3B annual revenue, - 3.0B losses persist (-93.5% margin) as of Qtr ending Mar 2025. Turnaround remains elusive.

6 years โ†“ -59.27%

Annaly Capital faces prolonged challenges with a 6-year decline (47.56 โ†’ 19.37), down 59.3% cumulatively. Weak margins on 179.2M annual revenue with only 130.3M profit (72.7% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

12 years โ†‘ 450.53%

Selective Insurance continues its impressive multi-year expansion with a 12-year growth streak (18.07 โ†’ 99.48), delivering 450.5% cumulative returns. With 1.3B annual revenue generating only 109.9M profit (8.6% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

8 years โ†‘ 757.63%

Agilysys demonstrates exceptional long-term growth with a 8-year growth streak (9.89 โ†’ 84.82), delivering 757.6% cumulative returns. With 74.3M annual revenue generating only 3.9M profit (5.3% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

7 years โ†“ -77.39%

Paramount Global faces prolonged challenges with a 7-year decline (65.41 โ†’ 14.79), down 77.4% cumulatively. Weak margins on 7.2B annual revenue with only 161.0M profit (2.2% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

4 years โ†“ -81.14%

V.F faces prolonged challenges with a 4-year decline (99.67 โ†’ 18.80), down 81.1% cumulatively. Financial struggles compound yearly losses: despite 2.1B annual revenue, - 150.8M losses persist (-7.0% margin) as of Qtr ending Mar 2025. Turnaround remains elusive.

8 years โ†‘ 152.39%

Cts demonstrates exceptional long-term growth with a 8-year growth streak (17.33 โ†’ 43.74), delivering 152.4% cumulative returns. Annual financials validate this performance: 125.8M revenue generating 13.4M net profit (10.6% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

4 years โ†‘ 261.77%

Evolent Health maintains steady growth trajectory with a 4-year growth streak (9.13 โ†’ 33.03), delivering 261.8% cumulative returns. Despite 483.6M in annual revenue and - 64.6M loss (-13.4% margin) as of Qtr ending Mar 2025, the market values future potential over current profitability. Long-term investors bet on turnaround.

6 years โ†“ -92.59%

CommScope Holding faces prolonged challenges with a 6-year decline (38.05 โ†’ 2.82), down 92.6% cumulatively. Weak margins on 1.1B annual revenue with only 784.0M profit (70.5% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

6 years โ†“ -84.98%

Armour Residential endures extended market pressure with a 6-year decline (128.65 โ†’ 19.32), down 85.0% cumulatively. Weak margins on 29.7M annual revenue with only 27.3M profit (92.0% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

United States Market Yearly Gainers & Losers: 2023

Top United States Stock Gainers (2023)

Stock Year Open Year Close Yearly Change Avg Daily Volume Year Volume
$0.21 $51.26 31,937.50% 8.6K 2.2M
$14.85 $49.52 238.95% 469.8M 118.4B
$122.82 $353.96 194.13% 24.0M 6.1B
$6.58 $17.17 167.45% 58.6M 14.8B
$66.00 $147.41 127.59% 61.1M 15.4B
$4.81 $52.94 1,016.88% 19.2M 4.8B
$42.00 $23.47 456.16% 739.6K 186.4M
$10.02 $49.14 408.17% 17.3M 4.4B
$36.49 $173.92 391.44% 14.3M 3.6B
$19.96 $23.84 362.91% 18.4K 4.6M
$24.12 $22.58 20,427.27% 14.1K 3.6M
$94.64 $97.15 3,320.77% 568 143.1K
$2.09 $40.25 1,932.83% 397.8K 100.3M
$25.00 $25.10 1,318.08% 4.3K 1.1M
$2.18 $27.47 1,160.09% 14.3K 3.6M
$30.29 $34.48 28,633.33% 44.0K 11.1M
$0.25 $16.61 6,544.00% 417 105.2K
$0.12 $130.09 1,448.69% 12.0K 3.0M
$0.37 $3.85 1,032.35% 4.5M 1.1B
$7.44 $14.85 991.91% 1.2M 299.9M

Biggest United States Stock Losers (2023)

Stock Year Open Year Close Yearly Change Avg Daily Volume Year Volume
$178.04 $149.16 -16.90% 8.6M 2.2B
$176.16 $156.74 -11.27% 11.1M 2.8B
$109.78 $99.98 -9.36% 17.3M 4.4B
$18.51 $16.78 -8.85% 38.1M 9.6B
$63.56 $58.93 -7.36% 13.6M 3.4B
$28.00 $10.50 -62.35% 1.3K 322.9K
$274.61 $139.56 -48.98% 80.8K 20.4M
$35.69 $49.27 -48.90% 14.3M 3.6B
$247.70 $135.95 -44.79% 2.9M 742.0M
$51.01 $28.79 -43.81% 28.0M 7.1B
$1.20 $0.24 -99.63% 85.2K 21.5M
$18.11 $17.36 -70.27% 379.3K 95.6M
$8.91 $2.75 -68.43% 177.2K 44.7M
$10.26 $3.29 -67.93% 1.3M 325.3M
$5.30 $1.83 -64.94% 23.4M 5.9B
$2.02 $0.10 -95.05% 3.7K 931.7K
$1.46 $0.08 -94.37% 1.6M 396.7M
$0.63 $1.31 -89.44% 7.7K 2.0M
$41.40 $6.12 -84.96% 10.2M 2.6B
$74.12 $14.93 -79.65% 1.4M 348.3M

Most Active United States Stocks During 2023

Stock Year Open Year Close Yearly Change Avg Daily Volume Yearly Volume
$14.85 $49.52 238.95% 469.8M 118.4B
$118.47 $248.48 101.72% 136.2M 34.3B
$66.00 $147.41 127.59% 61.1M 15.4B
$130.28 $192.53 48.18% 58.7M 14.8B
$6.58 $17.17 167.45% 58.6M 14.8B
$11.82 $12.19 4.82% 57.6M 14.5B
$27.05 $50.25 90.12% 41.5M 10.5B
$4.65 $9.95 115.84% 40.6M 10.2B
$18.90 $23.46 27.29% 36.8M 9.3B
$8.24 $18.54 130.02% 35.0M 8.8B
$10.21 $9.07 -6.97% 51.9M 13.1B
$3.58 $23.49 586.84% 39.0M 9.8B
$6.97 $4.21 -38.36% 32.4M 8.2B
$12.91 $13.74 8.02% 27.5M 6.9B
$5.30 $1.83 -64.94% 23.4M 5.9B
$12.71 $4.50 -63.62% 24.5M 6.2B
$1.77 $3.18 82.76% 13.8M 3.5B
$6.64 $5.55 -14.35% 12.9M 3.2B
$24.60 $19.63 -18.28% 10.4M 2.6B
$41.40 $6.12 -84.96% 10.2M 2.6B

United States Sector Performance During 2023

Financial Services

84.25%
921 stocks
Top Performers by Market Cap:

Technology

53.79%
748 stocks
Top Performers by Market Cap:

Real Estate

24.44%
263 stocks
Top Performers by Market Cap:
Large Cap: IRM +40.38%
Small Cap: RDFN +143.40%

Industrials

24.09%
622 stocks
Top Performers by Market Cap:
Mega Cap: GE +95.13%
Large Cap: SYM +329.90%
Small Cap: LMB +336.79%

Healthcare

19.89%
1141 stocks
Top Performers by Market Cap:

Consumer Cyclical

19.12%
560 stocks
Top Performers by Market Cap:

Energy

12.15%
198 stocks
Top Performers by Market Cap:
Mega Cap: SHEL +15.54%
Large Cap: CCJ +90.12%
Mid Cap: TDW +95.69%
Small Cap: LPG +131.50%

Communication Services

11.86%
248 stocks
Top Performers by Market Cap:
Mega Cap: META +194.13%
Large Cap: APP +278.44%
Mid Cap: USM +99.23%
Small Cap: LGF.A +90.89%

Basic Materials

11.15%
255 stocks
Top Performers by Market Cap:
Mega Cap: LIN +25.92%
Large Cap: X +94.21%
Small Cap: AMR +131.52%

Consumer Defensive

8.56%
222 stocks
Top Performers by Market Cap:
Mega Cap: COST +44.60%
Large Cap: CELH +57.21%
Small Cap: UTI +86.31%

Utilities

-1.51%
95 stocks
Top Performers by Market Cap:
Large Cap: VST +66.03%
Mid Cap: RNW +39.27%
Small Cap: FLNC +39.07%

Data is updated regularly. Yearly performance is calculated based on closing prices.